Mayo forms enterprise executive leadership team, names four enterprise deputy directors

Two Neds—Ned David and Ned Sharpless—form Jupiter Bioventures and close $70M in initial financing

Jupiter Bioventures, a biotechnology venture foundry that builds science-driven therapeutics companies, announced the closing of a $70 million initial financing.

November 22, 2024

Vol.50 No.44

In Brief

Mayo Clinic, IgniteData collaborate to deploy data transfer platform

IgniteData announced a collaboration with Mayo Clinic to deploy its Archer platform across multiple sites in the U.S., aiming to improve the management of clinical trial data by enhancing the transfer of information from Electronic Health Records to Electronic Data Capture systems.

October 25, 2024

Vol.50 No.40

In Brief

Mayo Clinic receives $50M from Stephen M. and Barbara J. Slaggie to expand cancer care access

Mayo Clinic received a $50 million investment from Stephen M. and Barbara J. Slaggie of Marco Island, FL, and Winona, MN.

September 13, 2024

Vol.50 No.34

Clinical Roundup

Dysfunctional white blood cells linked to heightened melanoma risk

Mayo Clinic study has found that 8 million to 10 million Americans over age 40 have an overabundance of cloned white blood cells, or lymphocytes, that hamper their immune systems. Although many who have this condition—called monoclonal B-cell lymphocytosis—do not experience any symptoms, a recent study shows they may have an elevated risk for several health complications, including melanoma.

September 13, 2024

Vol.50 No.34

Clinical Roundup

Mayo Clinic performs world’s first known successful total larynx transplant in a patient with active cancer

A multidisciplinary team of doctors at Mayo Clinic in Arizona performed the third known total larynx transplant in the U.S.

July 12, 2024

Vol.50 No.28

Clinical Roundup

Cosylab, Mayo Clinic collaborate to advance radiation therapy, support the first carbon ion treatment facility in the U.S.

Cosylab, a provider of control systems and software solutions for complex and precise machines, has entered into a collaboration with Mayo Clinic to advance cancer care in the United States and beyond.

June 14, 2024

Vol.50 No.24

Mayo forms enterprise executive leadership team, names four enterprise deputy directors

YOU MAY BE INTERESTED IN

Two Neds—Ned David and Ned Sharpless—form Jupiter Bioventures and close $70M in initial financing

Mayo Clinic, IgniteData collaborate to deploy data transfer platform

Mayo Clinic receives $50M from Stephen M. and Barbara J. Slaggie to expand cancer care access

Dysfunctional white blood cells linked to heightened melanoma risk

Mayo Clinic performs world’s first known successful total larynx transplant in a patient with active cancer

Cosylab, Mayo Clinic collaborate to advance radiation therapy, support the first carbon ion treatment facility in the U.S.

Renew today!

Subscriber content

Never miss an issue!

Login